Xingxing Xie

Yaan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Comparison of effectiveness and safety of bexagliflozin and other sodium-glucose cotransporter 2 inhibitors for type 2 diabetes mellitus in adults: systematic review and network meta-analysis of randomized controlled trials.

Comparison of effectiveness and safety of bexagliflozin and other sodium-glucose cotransporter 2 inhibitors for type 2 diabetes mellitus in adults: systematic review and network meta-analysis of randomized controlled trials.

Journal: Frontiers in endocrinology
Published: March 31, 2026

Endothelial adenosine A2A receptor activation-mediated Tau hyperphosphorylation leads to blood-brain barrier breakdown in a chronic methamphetamine mouse model.

Endothelial adenosine A2A receptor activation-mediated Tau hyperphosphorylation leads to blood-brain barrier breakdown in a chronic methamphetamine mouse model.

Journal: Frontiers in medicine
Published: January 31, 2026

Treatment preference for once-weekly versus once-daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Treatment preference for once-weekly versus once-daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Journal: Annals of medicine
Published: December 27, 2025

Deacetylasperulosidic acid methyl ester attenuates liver fibrosis by modulating the SCFAs-Wnt/β-catenin signaling axis.

Deacetylasperulosidic acid methyl ester attenuates liver fibrosis by modulating the SCFAs-Wnt/β-catenin signaling axis.

Journal: European journal of pharmacology
Published: December 08, 2025

Temporal trends and demographic-geographic disparities in kidney Cancer mortality in the United States, 1999-2023.

Temporal trends and demographic-geographic disparities in kidney Cancer mortality in the United States, 1999-2023.

Journal: Preventive medicine reports
Published: August 16, 2025

Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials.

Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials.

Journal: Frontiers in immunology
Published: June 26, 2025

Risk factors for postoperative abdominal infection of colorectal cancer: A systematic review based on the PRISMA guidelines.

Risk factors for postoperative abdominal infection of colorectal cancer: A systematic review based on the PRISMA guidelines.

Journal: Medicine
Published: November 19, 2024

The effects of methimazole combined with propranolol on heart rate, bone metabolism, and thyroid hormone levels in patients with hyperthyroidism: A systematic review and a meta-analysis of case-control studies.

The effects of methimazole combined with propranolol on heart rate, bone metabolism, and thyroid hormone levels in patients with hyperthyroidism: A systematic review and a meta-analysis of case-control studies.

Journal: Medicine
Published: November 13, 2024

ω‑3 fatty acids in atherosclerotic cardiovascular disease (Review).

ω‑3 fatty acids in atherosclerotic cardiovascular disease (Review).

Journal: Biomedical reports
Published: February 01, 2024

Effects of abrocitinib on pruritus and eczema symptoms and tolerance in patients with moderate‑to‑severe atopic dermatitis in randomized, double‑blind and placebo‑controlled trials: A systematic review and a meta‑analysis.

Effects of abrocitinib on pruritus and eczema symptoms and tolerance in patients with moderate‑to‑severe atopic dermatitis in randomized, double‑blind and placebo‑controlled trials: A systematic review and a meta‑analysis.

Journal: Biomedical reports
Published: January 11, 2024

Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta‑analysis of eight short‑term, randomized, double‑blind, placebo‑controlled clinical trials.

Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta‑analysis of eight short‑term, randomized, double‑blind, placebo‑controlled clinical trials.

Journal: Biomedical reports
Published: October 20, 2023

Εfficacy and safety of vortioxetine (Lu AA21004) in the treatment of adult patients with major depressive disorder: A systematic review and a meta‑analysis of randomized controlled trials.

Εfficacy and safety of vortioxetine (Lu AA21004) in the treatment of adult patients with major depressive disorder: A systematic review and a meta‑analysis of randomized controlled trials.

Journal: Experimental and therapeutic medicine
Published: January 31, 2023
Showing 1-12 of 12

Last Updated: 09/26/2026